Rob Hoffman is a health and drug policy reporter at Herb. His work has also appeared in Politico, ThinkProgress, and Fusion.
While the reports in California are positive, for at least 21 other states, cannabis arrests have increased between 2014 and 2016—in some cases, by more than 50 percent.
NORML says the case is an example of unnecessary cannabis policing.
Andrew Panaggio was using opioids to treat his back pain until he found that cannabis offers relief without the side effects. His insurance company says they won’t pay for it.
The proposal is part of a movement to treat rather than punish drug users.
High driving turns out to be a lot more common than you might think.
Medical professionals in the state argued marijuana doesn’t need to be stronger than 12% THC, but patients are saying that’s not true.
Russia is calling on other G-7 nations to voice concern for Canada’s “high-handedness” following its decision to legalize recreational cannabis.
It was the third most common reason after family and running away from a problem.
Californian businesses are being forced by the California Bureau of Cannabis Control to destroy an obscene amount of cannabis products.
Due to the potential economic benefits of allowing cannabis businesses to thrive, leaders of 15 Caribbean nations will be debating whether or not to decriminalize cannabis.
According to a recent report, top officials at the VA were pushing internally for research into the medical application of cannabis for health issues facing veterans such as PTSD.
L.A. was supposed to be one of the nation’s largest cannabis markets, but businesses are now leaving for elsewhere in the state amid a slow licensing process.
The case is likely to end up in the Arizona Supreme Court.
This would transform the booming CBD market.
California has granted 20% of the state’s cultivation licenses to just 12 growers.
Not all cannabis advocates are happy with how things turned out in Canada.
The most popular strain among those with migraines was OG Shark.
Once again, the outdated gateway drug theory has been disproven.
Twenty-six percent of tested products contained less CBD than the package suggested. Forty-three percent contained more.
Federal laws have to change so Epidiolex can get to market. Will it impact other CBD products?